Huntleigh Advisors, Inc. Apyx Medical Corp Transaction History
Huntleigh Advisors, Inc.
- $592 Billion
- Q4 2025
A detailed history of Huntleigh Advisors, Inc. transactions in Apyx Medical Corp stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 236,398 shares of APYX stock, worth $917,224. This represents 0.14% of its overall portfolio holdings.
Number of Shares
236,398Holding current value
$917,224% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding APYX
# of Institutions
54Shares Held
17.6MCall Options Held
130KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.34MShares$13 Million0.29% of portfolio
-
Archon Capital Management LLC Seattle, WA3.28MShares$12.7 Million4.92% of portfolio
-
Royce & Associates LP2.47MShares$9.6 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$6.07 Million0.0% of portfolio
-
Silverberg Bernstein Capital Management LLC Armonk, NY1.03MShares$4.01 Million2.09% of portfolio
About Apyx Medical Corp
- Ticker APYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 34,573,000
- Market Cap $134M
- Description
- Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...